Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This finding held true regardless of individuals’ initial weight, unless they had obesity, in a recent large study.
People who switched from tenofovir disoproxil fumarate to tenofovir alafenamide gained weight regardless of other meds.
A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections
Studies have found that weight gain is common after people with HIV begin an antiretroviral in this class.
Weight gain speeds up after switching to an integrase inhibitor from a non-nucleoside reverse transcriptase inhibitor.
“I’m putting my fat rolls and fine lines on full display as a commitment to value myself,” says Kelly Gluckman of Through Positive Eyes.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
Newer drug classes are tied to a higher risk of weight gain, which is more likely to occur among Black women in particular.
Researchers at George Washington University take a look.
Future research should examine how particular combinations of antiretrovirals contribute to weight gain, according to one expert.
The newer tenofovir formulation can raise cholesterol and triglyceride levels, but these changes are reversible.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.